Cite
HARVARD Citation
Tsukita, Y. et al. (2021). Intensity-modulated radiation therapy with concurrent chemotherapy followed by durvalumab for stage III non-small cell lung cancer: A multi-center retrospective study. Radiotherapy and oncology. pp. 266-272. [Online].